SCHEMBL6710020

SCHEMBL6710020

CC(C)CC(=O)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.41
PLCG2 P16885 1/20 0.39
CASP3 P42574 1/20 0.38
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TP53 P04637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
PLA2G7 Q13093 1/20 0.36
PTK2B Q14289 1/20 0.36
F11 P03951 2/20 0.36
KLKB1 P03952 2/20 0.36
NHERF1 O14745 2/20 0.36
MAP3K5 Q99683 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
CMKLR1 Q99788 2/20 0.36
NSD2 O96028 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
STK33 Q9BYT3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709877 0.91 GRIK1 (0.43) GRIK1PLCG2MAPTMAPK1TDP1
SCHEMBL6707917 0.91 GRIK1 (0.38) GRIK1PLCG2MAPTMAPK1TDP1
SCHEMBL6710057 0.90 GRIK1 (0.39) GRIK1MAPTMAPK1TDP1TP53
SCHEMBL6712433 0.89 GRIK1 (0.42) GRIK1PLCG2MAPTMAPK1TDP1
SCHEMBL6712543 0.89 GRIK1 (0.43) GRIK1PLCG2MAPTTP53RXFP1
SCHEMBL6713948 0.89 GRIK1 (0.41) GRIK1PLCG2MAPTMAPK1TP53
SCHEMBL6711365 0.89 GRIK1 (0.41) GRIK1PLCG2MAPTTP53PLA2G7
SCHEMBL6713838 0.89 GRIK1 (0.41) GRIK1PLCG2MAPTTP53PLA2G7
SCHEMBL6712528 0.88 GRIK1 (0.39) GRIK1PLCG2MAPTMAPK1TDP1
SCHEMBL6709173 0.88 GRIK1 (0.44) GRIK1PLCG2MAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885PLCG2 4289/4885CASP3 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.